GrowX Ventures

GrowX Ventures is a New Delhi-based B2B-focused early-stage investment firm writing pre-seed and seed checks in the $250K to $1M range, with active interest in AI and deep-tech applications across multiple verticals including healthcare. Within healthcare, the firm engages with digital health and AI/ML platforms with credible enterprise GTM, and the partner team’s pattern recognition is concentrated in B2B software and applied AI rather than consumer or clinical-services models. The geographic focus is India with global commercial ambition, and the Delhi-NCR headquarters connects the firm to the broader North Indian operator and engineering community, including alumni of companies like MakeMyTrip, Policybazaar, and BharatPe. The right founder profile is an engineering-led team building B2B SaaS or applied AI for healthcare enterprise buyers, with technical depth and a credible product wedge that creates a defensible moat against horizontal AI infrastructure providers. The wrong fit is a clinical-services business, a hardware-heavy medtech device, or a consumer health brand; GrowX is not a healthcare specialist. The right entry path is through Delhi-NCR founder networks, through alumni of B2B SaaS companies that have scaled internationally, through accelerators like Surge and Y Combinator, and through warm introductions from co-investors at firms like Blume, Kalaari, and 3one4. The team is reachable through targeted outreach when the product is sharp, but warm intros materially improve diligence speed. When pitching, lead with the enterprise GTM, the AI capability, the customer logos, and the ARR trajectory; the partners are pattern-matching against B2B SaaS metrics. Avoid leading with a clinical-impact narrative; that can be layered in once the commercial story has landed. Caveats: GrowX is a smaller fund with limited follow-on capacity, and founders should plan for institutional Series A capital from larger Indian and US firms as the metrics warrant. The healthcare-specific operating expertise is also generalist rather than specialist, so layering clinical-domain advisors and specialist co-investors onto the cap table is sensible. Use GrowX as a sharp, technically credible early-stage partner for a B2B AI-for-healthcare company.